Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Inspections

Inspections are an official task carried out by the Paul-Ehrlich-Institut (PEI) and are used to verify actual conditions on-site, e.g. at pharmaceutical companies, sponsors and service providers, as well as in laboratories and test centres.

The Paul-Ehrlich-Institut carries out inspections worldwide:

  • to verify compliance with good clinical practice (GCP) in national clinical trial approval procedures or within the framework of national or centralised European marketing authorisation procedures (GCP inspections),
  • within the European Plasma Master File (PMF) certification procedure for verifying information related to human plasma as a starting material for manufacturing of medicinal products (PMF inspections),
  • to evaluate medicinal product safety systems (human and veterinary pharmacovigilance, tissue vigilance, haemovigilance, and inspections) at the national and European level,
  • within the national marketing authorisation procedure to verify submitted data.

In addition, experts from the Paul-Ehrlich-Institut accompany inspections conducted by the competent federal state authorities in the course of issuing authorisations and certificates as well as in routine monitoring.

The Paul-Ehrlich-Institut staff and the federal state authority staff cooperate closely during these inspections.

Contact

Inspections of Biomedicines Section
Email: inspektionen@pei.de

Updated: 04.07.2025